MEDIAN TECHNOLOGIES (EPA:ALMDT) | Finanzwire

Basculer en Français

9979	Companies
202294	Keywords
132916	Articles
107422	Press releases

Home
Companies
MEDIAN TECHNOLOGIES

BRIEF

published on 02/12/2026 at 22:10, 20 days 15 hours ago

Median Technologies and Tempus Partner to Expand Lung Cancer Screening in the U.S.

FDA Clearance Median Technologies Lung Cancer Screening Eyonis® LCS Tempus AI
PRESS RELEASE

published on 02/12/2026 at 22:05, 20 days 15 hours ago

Inside Information / Other news releases
Median Technologies collaborates with Tempus to expand access to eyonis® LCS Software as a Medical Device in the US following FDA 510(k) clearance, enhancing lung cancer screening with AI tools

FDA Clearance AI Tools Median Technologies Eyonis® LCS Tempus
BRIEF

published on 02/11/2026 at 17:50, 21 days 20 hours ago

Median Technologies Announces Voting Rights Update

Voting Rights Shares Treasury Shares Euronext Growth French Regulation
BRIEF

published on 02/11/2026 at 17:50, 21 days 20 hours ago

Declaration of the Number of Voting Rights and Shares of Median Technologies

Share Capital Voting Rights Treasury Shares Euronext Growth Median Technologies
PRESS RELEASE

published on 02/11/2026 at 17:45, 21 days 20 hours ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Disclosure of total voting rights and shares as of Jan 31, 2026 by Median Technologies. Cutting-edge AI for cancer diagnoses and treatments. Listed on Euronext Growth market

Voting Rights Shares AI Median Technologies Cancer Diagnoses
BRIEF

published on 02/09/2026 at 07:05, 24 days 6 hours ago

Median Technologies receives FDA 510(k) clearance for eyonis® LCS

FDA AI Technology Median Technologies Lung Cancer Screening Eyonis® LCS
BRIEF

published on 02/09/2026 at 07:05, 24 days 6 hours ago

FDA Clearance Granted for Median Technologies' AI-based Lung Cancer Device

FDA Clearance AI Technology Lung Cancer Screening Eyonis® LCS Reimbursement Pathway
PRESS RELEASE

published on 02/09/2026 at 07:00, 24 days 6 hours ago

Inside Information / Operations of the issuer (acquisitions, sales...)
Median Technologies receives FDA 510(k) clearance for eyonis® LCS, the first AI tech-based detection and diagnosis device for lung cancer screening. The device aims to redefine lung cancer screening with high accuracy and potential to save lives

FDA Clearance AI Technology Median Technologies Eyonis LCS Lung Cancer Screening
BRIEF

published on 01/14/2026 at 17:50, 1 month 21 days ago

Median Technologies: Financial Calendar and Conference Participation in 2026

Investor Conferences Financial Calendar Annual Results Median Technologies AI-powered Medical Imaging
BRIEF

published on 12/03/2025 at 17:50, 3 months 1 day ago

Median Technologies Reveals Voting Rights and Share Capital Structure

Share Capital Voting Rights Regulatory Compliance Financial Transparency Median Technologies

1 2 ... 5

Accesswire

Published on 03/05/2026 at 13:40, 14 minutes ago

Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
Published on 03/05/2026 at 13:30, 24 minutes ago

Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend
Published on 03/05/2026 at 13:30, 24 minutes ago

Nextech3D.ai Expands AI Event Technology Into New Markets and Implements 20%-30% Enterprise Price Increase
Published on 03/05/2026 at 13:00, 54 minutes ago

Revolve Signs Definitive Agreements for Portfolio of 16 Distributed Generation Solar Projects in Mexico
Published on 03/05/2026 at 13:00, 54 minutes ago

Field Work Identifies New Mineralized Trend and Additional Gold Targets at Golden Rose

View all ACCESSWIRE

EQS Group

Published on 03/05/2026 at 13:43, 11 minutes ago

Healthcare specialist SHS Capital exits AMW, a leading specialty pharma company, and continues partnership by reinvesting with its current fund as part of a syndicate of investors
Published on 03/05/2026 at 13:25, 28 minutes ago

Huawei and SOLUM Unveil Shop-in-Shop Smart Converged Network Solution to Accelerate Retail Intelligence
Published on 03/05/2026 at 13:06, 47 minutes ago

HENSOLDT acquires Nedinsco and expands its European presence
Published on 03/05/2026 at 13:05, 48 minutes ago

Norgine announces £23 million new investment as part of more than £50 million committed to expanding medicines manufacturing in Wales
Published on 03/05/2026 at 13:00, 53 minutes ago

Huawei Launches AI Data Platform to Bridge Models and Business Value

Les Echos

Published on 03/05/2026 at 13:20, 33 minutes ago

Voting rights
Published on 03/05/2026 at 07:30, 6 hours 24 minutes ago

Share buyback finalized
Published on 03/04/2026 at 23:50, 14 hours 4 minutes ago

Total number of voting rights and shares making up the share capital at February 28, 2026
Published on 03/04/2026 at 18:00, 19 hours 53 minutes ago

Disclosure of Share Capital and Voting Rights as of February 28, 2026
Published on 03/04/2026 at 17:45, 20 hours 9 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE